Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
Public ClinicalTrials.gov record NCT01344187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.
Study identification
- NCT ID
- NCT01344187
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 236 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2012
- Primary completion
- May 31, 2015
- Completion
- May 31, 2016
- Last update posted
- Apr 25, 2021
2012 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Irvine Department of Ophthalmology | Irvine | California | 92697 | — |
| Bascolm Palmer Eye Institute | Miami | Florida | 33136 | — |
| Emory Eye Center | Atlanta | Georgia | 30342 | — |
| Ophthalmic Consultants of Boston | Waltham | Massachusetts | 02451 | — |
| Kugler Vision | Omaha | Nebraska | 68144 | — |
| Pinceton Eye Goup | Princeton | New Jersey | 08540 | — |
| Comprehensive Eye Care of Central Ohio | Westerville | Ohio | 43082 | — |
| Medical University of South Carolina Storm Eye Institute, Magill Vision Center | Mt. Pleasant | South Carolina | 29464 | — |
| Vance Thompson Vision | Sioux Falls | South Dakota | 57108 | — |
| Hoopes Vision | Draper | Utah | 84020 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01344187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2021 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01344187 live on ClinicalTrials.gov.